ARTICLE | Company News
Psyadon, Schering-Plough deal
November 17, 2008 8:00 AM UTC
Schering-Plough granted Psyadon (formerly Ruxton Pharmaceuticals Inc.) an exclusive, worldwide license to develop and commercialize ecopipam (formerly SCH 39166) for all indications. Ecopipam was in ...